QuickSeq is an Israeli sequencing marketplace and advisory that guides you through next-generation sequencing end-to-end, from sample preparation and library construction through sequencing and full bioinformatic analysis. We advise on the best strategy, match you with the right provider for your project, and manage it from sample collection to final results. We serve academic researchers, biotech companies, and clinical labs that need fast turnaround, scientific depth, and a team that actually understands their data.
Our Founders
Dr. Oded Edelheit is a molecular biologist, biotechnology entrepreneur, and technology leader with more than 20 years of experience in life sciences, genomics, biotechnology, and translational research. Throughout his career, he has combined scientific expertise with technological innovation, transforming advanced research into practical solutions for biotechnology, healthcare, and scientific discovery.
As a scientist and entrepreneur, Dr. Edelheit has founded and contributed to multiple life science ventures focused on genomics, molecular diagnostics, biotechnology services, and research infrastructure. His multidisciplinary background enables him to bridge the gap between scientific research and technological implementation, creating solutions that address the evolving needs of researchers and biotechnology organizations.
As Co-Founder and Chief Technology Officer of QuickSeq, Dr. Edelheit leads the company's technology vision and innovation strategy, driving the development of advanced genomics and sequencing solutions.
With a strong passion for both science and entrepreneurship, Dr. Edelheit focuses on building innovative platforms and strategic partnerships that enable scientific progress. His vision is to make advanced genomics technologies more accessible and efficient, empowering researchers and organizations to achieve faster and more impactful breakthroughs.
Dr. Ronen Hope is a molecular biologist and genomics expert with a Ph.D. from Bar-Ilan University and more than 15 years of experience in research, development, and the implementation of advanced technologies in molecular biology, genetics, and biotechnology.
Throughout his career, Dr. Hope has led innovative scientific projects in genomics and next-generation sequencing (NGS). His work bridges cutting-edge research with practical applications in life sciences and healthcare, contributing to the development of novel technologies and advancements in the biotechnology sector.
As Co-Founder and Chief Scientific Officer (CSO) of QuickSeq, Dr. Hope leads the company's scientific strategy, overseeing the development of advanced sequencing solutions and genomics services for researchers, biotechnology companies, and pharmaceutical organizations. His expertise ensures the delivery of high-quality, reliable, and innovative solutions tailored to the evolving needs of the life sciences industry.
Driven by a passion for scientific excellence and innovation, Dr. Hope is committed to making advanced genomic technologies more accessible, empowering researchers and organizations to accelerate discovery, development, and translational research through accurate and actionable genomic insights.
Tell us about your project and we'll get back to you with a quote.
